MenAfriVac as an Antitetanus Vaccine

Background. The group A meningococcal conjugate vaccine, PsA-TT, uses tetanus toxoid (TT) as a carrier protein (PsA-TT). TT as a carrier protein in other conjugate vaccines is known to be immunogenic and generates a robust anti-TT response. Methods. Clinical studies in Africa assessed whether PsA-TT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Borrow, Ray, Tang, Yuxiao, Yakubu, Ahmadu, Kulkarni, Prasad S., LaForce, F. Marc
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639489/
https://ncbi.nlm.nih.gov/pubmed/26553690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ512
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi